相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。JNK signaling in cancer cell survival
Qinghua Wu et al.
MEDICINAL RESEARCH REVIEWS (2019)
JNK, p38, ERK, and SGK1 Inhibitors in Cancer
Jonas Cicenas et al.
CANCERS (2018)
In silico-in vitro discovery of untargeted kinase-inhibitor interactions from kinase-targeted therapies: A case study on the cancer MAPK signaling pathway
Li Meng et al.
COMPUTATIONAL BIOLOGY AND CHEMISTRY (2018)
TRPM2 channel-mediated regulation of autophagy maintains mitochondrial function and promotes gastric cancer cell survival via the JNK-signaling pathway
Shekoufeh Almasi et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2018)
Tumor necrosis factor receptor-associated factor 6 mediated the promotion of salivary adenoid cystic carcinoma progression through Smad-p38-JNK signaling pathway induced by TGF-
Yancan Liang et al.
JOURNAL OF ORAL PATHOLOGY & MEDICINE (2018)
Chemotherapy-Induced Tunneling Nanotubes Mediate Intercellular Drug Efflux in Pancreatic Cancer
Snider Desir et al.
SCIENTIFIC REPORTS (2018)
Foxo1 Attenuates NaF-Induced Apoptosis of LS8 Cells through the JNK and Mitochondrial Pathways
Juedan Li et al.
BIOLOGICAL TRACE ELEMENT RESEARCH (2018)
TGF-β Down-regulates Apolipoprotein M Expression through the TAK-1-JNK-c-Jun Pathway in HepG2 Cells
Kun Ren et al.
LIPIDS (2017)
37LRP induces invasion in hypoxic lung adenocarcinoma cancer cells A549 through the JNK/ERK/c-Jun signaling cascade
Yongan Zhou et al.
TUMOR BIOLOGY (2017)
Role of JNK signaling in oral cancer: A mini review
Ioannis Gkouveris et al.
TUMOR BIOLOGY (2017)
A c-Jun N-terminal kinase inhibitor, JNK-IN-8, sensitizes triple negative breast cancer cells to lapatinib
Nancy D. Ebelt et al.
ONCOTARGET (2017)
Activation of a c-Jun N-terminal kinase-mediated autophagy pathway attenuates the anticancer activity of gemcitabine in human bladder cancer cells
Xiao-Long Huang et al.
ANTI-CANCER DRUGS (2017)
IL33 Promotes Colon Cancer Cell Stemness via JNK Activation and Macrophage Recruitment
Min Fang et al.
CANCER RESEARCH (2017)
Attenuated JNK signaling in multidrug-resistant leukemic cells. Dual role of MAPK in cell survival
David Cerezo et al.
CELLULAR SIGNALLING (2017)
Interleukin-33 predicts poor prognosis and promotes ovarian cancer cell growth and metastasis through regulating ERK and JNK signaling pathways
Xiaoguang Tong et al.
MOLECULAR ONCOLOGY (2016)
A multicenter, single-arm, open-label, phase 2 study of apitolisib (GDC-0980) for the treatment of recurrent or persistent endometrial carcinoma (MAGGIE study)
Vicky Makker et al.
CANCER (2016)
PI3K p110β isoform synergizes with JNK in the regulation of glioblastoma cell proliferation and migration through Akt and FAK inhibition
Hua-Fu Zhao et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2016)
JNK Signaling: Regulation and Functions Based on Complex Protein-Protein Partnerships
Andras Zeke et al.
MICROBIOLOGY AND MOLECULAR BIOLOGY REVIEWS (2016)
Elevated STC-1 augments the invasiveness of triple-negative breast cancer cells through activation of the JNK/c-Jun signaling pathway
Jeonghun Han et al.
ONCOLOGY REPORTS (2016)
Identification of p62/SQSTM1 as a component of non-canonical Wnt VANGL2-JNK signalling in breast cancer
Tania M. Puvirajesinghe et al.
NATURE COMMUNICATIONS (2016)
The novel JNK inhibitor AS602801 inhibits cancer stem cells in vitro and in vivo
Masashi Okada et al.
ONCOTARGET (2016)
Co-Targeting of JNK and HUNK in Resistant HER2-Positive Breast Cancer
Kendall Phelps-Polirer et al.
PLOS ONE (2016)
mTORC1 pathway mediates beta cell compensatory proliferation in 60 % partial-pancreatectomy mice
Wenyi Li et al.
ENDOCRINE (2016)
ROS activates JNK-mediated autophagy to counteract apoptosis in mouse mesenchymal stem cells in vitro
Guan-yu Liu et al.
ACTA PHARMACOLOGICA SINICA (2015)
Crosstalk between JNK and NF-κB signaling pathways via HSP27 phosphorylation in HepG2 cells
Jie Ruan et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2015)
CIP2A overexpression induces autoimmune response and enhances JNK signaling pathway in human lung cancer
Bo Peng et al.
BMC CANCER (2015)
Phase I study of OPB-51602, an oral inhibitor of signal transducer and activator of transcription 3, in patients with relapsed/refractory hematological malignancies
Michinori Ogura et al.
CANCER SCIENCE (2015)
JNK pathway signaling: a novel and smarter therapeutic targets for various biological diseases
Ankit Kumar et al.
FUTURE MEDICINAL CHEMISTRY (2015)
Phase 1 and pharmacological trial of OPB-31121, a signal transducer and activator of transcription-3 inhibitor, in patients with advanced hepatocellular carcinoma
Takuji Okusaka et al.
HEPATOLOGY RESEARCH (2015)
Phosphorylation of Glutathione S-Transferase P1 (GSTP1) by Epidermal Growth Factor Receptor (EGFR) Promotes Formation of the GSTP1-c-Jun N-terminal kinase (JNK) Complex and Suppresses JNK Downstream Signaling and Apoptosis in Brain Tumor Cells
Tatsunori Okamura et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2015)
DUSP4 deficiency caused by promoter hypermethylation drives JNK signaling and tumor cell survival in diffuse large B cell lymphoma
Corina A. Schmid et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2015)
The c-Jun N-terminal kinase inhibitor SP600125 inhibits human cytomegalovirus replication
Huiping Zhang et al.
JOURNAL OF MEDICAL VIROLOGY (2015)
Subconjunctival Injection of XG-102, a JNK Inhibitor Peptide, in Patients with Intraocular Inflammation: A Safety and Tolerability Study
Talal Beydoun et al.
JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS (2015)
Ginsenoside Rg1 Ameliorates Motor Function in an Animal Model of Parkinson's Disease
Wenda Jiang et al.
PHARMACOLOGY (2015)
Ginsenoside Rg1, a potential JNK inhibitor, protects against ischemia/reperfusion-induced liver damage
Xiao-Jing Zhang et al.
JOURNAL OF FUNCTIONAL FOODS (2015)
Pyridopyrimidinone Derivatives as Potent and Selective c-Jun N-Terminal Kinase (JNK) Inhibitors
Ke Zheng et al.
ACS MEDICINAL CHEMISTRY LETTERS (2015)
SP600125 has a remarkable anticancer potential against undifferentiated thyroid cancer through selective action on ROCK and p53 pathways
Elisa Stellaria Grassi et al.
ONCOTARGET (2015)
GRP78 promotes the invasion of pancreatic cancer cells by FAK and JNK
X. P. Yuan et al.
MOLECULAR AND CELLULAR BIOCHEMISTRY (2015)
Targeting JNK-interacting-protein-1 (JIP1) sensitises osteosarcoma to doxorubicin
Jantine PosthumadeBoer et al.
Oncotarget (2015)
Inhibition of JNK2 and JNK3 by JNK inhibitor IX induces prometaphase arrest-dependent apoptotic cell death in human Jurkat T cells
Won Young Jang et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2014)
Synthesis and SAR of novel isoxazoles as potent c-jun N-terminal kinase (JNK) inhibitors
Yuanjun He et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2014)
JNK signalling in cancer: in need of new, smarter therapeutic targets
Concetta Bubici et al.
BRITISH JOURNAL OF PHARMACOLOGY (2014)
Crosstalk of JNK1-STAT3 is critical for RAW264.7 cell survival
Qinghua Wu et al.
CELLULAR SIGNALLING (2014)
Recent Progress in the Design, Study, and Development of c-Jun N-Terminal Kinase Inhibitors as Anticancer Agents
Abdellah Messoussi et al.
CHEMISTRY & BIOLOGY (2014)
Acentrosomal Drosophila Epithelial Cells Exhibit Abnormal Cell Division, Leading to Cell Death and Compensatory Proliferation
John S. Poulton et al.
DEVELOPMENTAL CELL (2014)
The Role of Hepatic Ischemia-Reperfusion Injury and Liver Parenchymal Quality on Cancer Recurrence
Lorenzo A. Orci et al.
DIGESTIVE DISEASES AND SCIENCES (2014)
Alkyl chain substituted 1,9-pyrazoloanthrones exhibit prominent inhibitory effect on c-Jun N-terminal kinase (JNK)
Karothu Durga Prasad et al.
ORGANIC & BIOMOLECULAR CHEMISTRY (2014)
Immune-mediated tumor evolution: Nanog links the emergence of a stem like cancer cell state and immune evasion
Chih-Ping Mao et al.
ONCOIMMUNOLOGY (2014)
JNK activation is required for TNFα-induced apoptosis in human hepatocarcinoma cells
Valerio Giacomo Minero et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2013)
Specific role of JNK in the maintenance of the tumor-initiating capacity of A549 human non-small cell lung cancer cells
Masashi Okada et al.
ONCOLOGY REPORTS (2013)
JNK and Macroautophagy Activation by Bortezomib Has a Pro-Survival Effect in Primary Effusion Lymphoma Cells
Marisa Granato et al.
PLOS ONE (2013)
RIP3 Inhibits Inflammatory Hepatocarcinogenesis but Promotes Cholestasis by Controlling Caspase-8-and JNK-Dependent Compensatory Cell Proliferation
Mihael Vucur et al.
CELL REPORTS (2013)
Discovery of a novel series of 4-quinolone JNK inhibitors
Leyi Gong et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2012)
Discovery of CC-930, an orally active anti-fibrotic JNK inhibitor
Veronique Plantevin Krenitsky et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2012)
Discovery of Potent and Selective Covalent Inhibitors of JNK
Tinghu Zhang et al.
CHEMISTRY & BIOLOGY (2012)
Phase I pharmacokinetic and pharmacodynamic study of the pan-PI3K/mTORC vascular targeted pro-drug SF1126 in patients with advanced solid tumours and B-cell malignancies
D. Mahadevan et al.
EUROPEAN JOURNAL OF CANCER (2012)
Activation of JNK/c-Jun is required for the proliferation, survival, and angiogenesis induced by EET in pulmonary artery endothelial cells
Jun Ma et al.
JOURNAL OF LIPID RESEARCH (2012)
The JNK inhibitor D-JNKI-1 blocks apoptotic JNK signaling in brain mitochondria
Yi Zhao et al.
MOLECULAR AND CELLULAR NEUROSCIENCE (2012)
Rosiglitazone and AS601245 Decrease Cell Adhesion and Migration through Modulation of Specific Gene Expression in Human Colon Cancer Cells
Angelo Cerbone et al.
PLOS ONE (2012)
AS601245, an Anti-Inflammatory JNK Inhibitor, and Clofibrate Have a Synergistic Effect in Inducing Cell Responses and in Affecting the Gene Expression Profile in CaCo-2 Colon Cancer Cells
Angelo Cerbone et al.
PPAR RESEARCH (2012)
Identification of an Adamantyl Azaquinolone JNK Selective Inhibitor
Nancy-Ellen Haynes et al.
ACS MEDICINAL CHEMISTRY LETTERS (2012)
Pro-survival effects of JNK and p38 MAPK pathways in LPS-induced activation of BV-2 cells
Christina Svensson et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2011)
Characterization of a novel JNK (c-Jun N-terminal kinase) inhibitory peptide
Kevin R. W. Ngoei et al.
BIOCHEMICAL JOURNAL (2011)
Highly selective c-Jun N-terminal kinase (JNK) 3 inhibitors with in vitro CNS-like pharmacokinetic properties II. Central core replacement
R. Jeffrey Neitz et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2011)
Synthesis and SAR of novel quinazolines as potent and brain-penetrant c-jun N-terminal kinase (JNK) Inhibitors
Yuanjun He et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2011)
Contribution of persistent C-Jun N-terminal kinase activity to the survival of human vestibular schwannoma cells by suppression of accumulation of mitochondrial superoxides
Wei Ying Yue et al.
NEURO-ONCOLOGY (2011)
Evading tumor evasion: Current concepts and perspectives of anti-angiogenic cancer therapy
Amir Abdollahi et al.
DRUG RESISTANCE UPDATES (2010)
Targeting the RAF-MEK-ERK pathway in cancer therapy
Clara Montagut et al.
CANCER LETTERS (2009)
Selective inhibition of JNK with a peptide inhibitor attenuates pain hypersensitivity and tumor growth in a mouse skin cancer pain model
Yong-Jing Gao et al.
EXPERIMENTAL NEUROLOGY (2009)
A selective small-molecule inhibitor of c-Jun N-terminal kinase 1
Ke Yao et al.
FEBS LETTERS (2009)
Signal integration by JNK and p38 MAPK pathways in cancer development
Erwin F. Wagner et al.
NATURE REVIEWS CANCER (2009)
Discovery, synthesis and biological evaluation of isoquinolones as novel and highly selective JNK inhibitors (1)
Yasutomi Asano et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2008)
Identification of a new JNK inhibitor targeting the JNK-JIP interaction site
John L. Stebbins et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
The functional contrariety of JNK
Ann M. Bode et al.
MOLECULAR CARCINOGENESIS (2007)
Patterns of somatic mutation in human cancer genomes
Christopher Greenman et al.
NATURE (2007)
N-(3-cyano-4,5,6,7-tetrahydro-1-benzothien-2-yl)amides as potent, selective, inhibitors of JNK2 and JNK3
Richard M. Angell et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2007)
Chemical genetic analysis of the time course of signal transduction by JNK
JJ Ventura et al.
MOLECULAR CELL (2006)
Design and synthesis of 2′-anilino-4,4′-bipyridines as selective inhibitors of e-Jun N-terminal kinase-3
BM Swahn et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2006)
The JNK are important for development and survival of macrophages
SR Himes et al.
JOURNAL OF IMMUNOLOGY (2006)
Design and synthesis of 6-anilinoindazoles as selective inhibitors of c-Jun N-terminal kinase-3
BM Swahn et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2005)
c-Jun N-terminal kinase (JNK) is required for survival and proliferation of B-lymphoma cells
M Gururajan et al.
BLOOD (2005)
From JNK to pay dirt: Jun kinases, their biochemistry, physiology and clinical importance
M Karin et al.
IUBMB LIFE (2005)
Role of JNK activation in apoptosis: A double-edged sword
J Liu et al.
CELL RESEARCH (2005)
Apoptotic cells can induce compensatory cell proliferation through the JNK and the wingless signaling pathways
HD Ryoo et al.
DEVELOPMENTAL CELL (2004)
A JNK-dependent pathway is required for TNFα-induced apoptosis
YB Deng et al.
CELL (2003)
A peptide inhibitor of c-Jun N-terminal kinase protects against excitotoxicity and cerebral ischemia
T Borsello et al.
NATURE MEDICINE (2003)
Targeting JNK for therapeutic benefit: From JuNK to gold?
AM Manning et al.
NATURE REVIEWS DRUG DISCOVERY (2003)
JunD mediates survival signaling by the JNK signal transduction pathway
JA Lamb et al.
MOLECULAR CELL (2003)
Activation of the JNK signaling pathway: breaking the brake on apoptosis
A Lin
BIOESSAYS (2003)
The absence of NF-κB-mediated inhibition of c-Jun N-terminal kinase activation contributes to tumor necrosis factor alpha-induced apoptosis
FM Tang et al.
MOLECULAR AND CELLULAR BIOLOGY (2002)
Activation of JNK by TPA promotes apoptosis via PKC pathway in gastric cancer cells
Y Chen et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2002)
SP600125, an anthrapyrazolone inhibitor of Jun N-terminal kinase
BL Bennett et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
Novel role for JNK as a stress-activated Bcl2 kinase
XM Deng et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
分享论文
